João Costa, José M. Ferro, Jordi Matias-Guiu
2006
Citations
0
Influential Citations
37
Citations
Quality indicators
Journal
Stroke
Abstract
Aspirin is still considered the standard treatment for secondary prevention of stroke and other vascular events. Because several studies suggested that triflusal (an antiplatelet agent structurally related to aspirin) may have a better safety profile, and the uncertainty of its efficacy when compared with aspirin, we performed a Cochrane systematic review to determine whether triflusal is an effective and safe treatment for primary and secondary prevention of serious vascular events among people at high risk.1 Relevant trials were identified in the trials registers of the Stroke, Heart and Peripheral Vascular Diseases Cochrane Review Groups, and by electronic search of the …